Delivery Order SPE2DR25D1109-SPE2DR26FFL3H
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,027.29 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, utilized firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $4,464.08 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and represents a non-competitive award under an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is...
- The Defense Logistics Agency awarded a $4,058.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract was competitively awarded without set-aside provisions and is scheduled for completion by October 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $49,858.85 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and was awarded on January 6, 2026 without set-aside provisions, indicating competitive award. Performance will be executed from...
- The Defense Logistics Agency awarded a $9,510.54 delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of January 22, 2026, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a $18,224.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract was competitively awarded without set-aside provisions and is scheduled for completion on November 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $12,803.72 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis and other autoimmune conditions. This competitively awarded, non-set-aside contract employs firm fixed price pricing and was issued on January 23, 2026, with an ultimate completion date of January 26, 2026. The place of performance is listed as AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $11,053.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside delivery order executed through the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $44,496.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This non-set-aside competitive award is set to conclude on January 6, 2026, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $6,637.09 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 13, 2026, and performance to be executed from the company's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFL3HDelivery Order
The Defense Logistics Agency awarded a $13,686.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This non-set-aside contract was competitively awarded on January 23, 2026, with an ultimate completion date of January 26, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying IDC covers medications across multiple therapeutic domains and enables efficient fulfillment of recurring federal pharmaceutical requirements for military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 1/22/26 |